Conduction properties of spinal cord axons in the myelin-deficient rat mutant

Neuroscience. 1992 Jul;49(1):221-8. doi: 10.1016/0306-4522(92)90090-o.

Abstract

Spinal cords of myelin-deficient and normal age-matched (control) rats were removed and their conduction and pharmacological properties studied in an in vitro brain slice chamber. The conduction velocity of the myelin-deficient dorsal column axons was reduced to about 25% of control axons; however, the amyelinated myelin-deficient axons displayed refractory periods and the ability to sustain high-frequency action potential discharge similar to that of dorsal column axons in control rats. Pharmacological results suggest that the myelin-deficient dorsal column axons qualitatively express a normal complement of ion channels and receptors. The demonstration of a normal representation of channels and receptors on these axons supports the proposal that the oligodendrocyte, and not the axon, is the site of the primary defect in the myelin-deficient rat mutant. It is concluded that, unlike acutely demyelinated axons which display marked frequency-dependent conduction block, amyelinated axons of the myelin-deficient rat spinal cord develop compensatory mechanisms to stabilize action potential conduction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Animals
  • Axons / drug effects
  • Axons / physiology*
  • Axons / ultrastructure
  • Electric Stimulation
  • Evoked Potentials / drug effects
  • Female
  • Male
  • Membrane Potentials
  • Microscopy, Electron
  • Myelin Sheath / physiology*
  • Neural Conduction*
  • Rats
  • Rats, Mutant Strains
  • Reference Values
  • Spinal Cord / drug effects
  • Spinal Cord / physiology*
  • Spinal Cord / ultrastructure
  • Tetrodotoxin / pharmacology
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Tetrodotoxin
  • gamma-Aminobutyric Acid
  • 4-Aminopyridine